# Dopamine in Acute Decompensated Heart Failure II

> **NCT01060293** · PHASE4 · TERMINATED · sponsor: **Larissa University Hospital** · enrollment: 161 (actual)

## Conditions studied

- Acute Decompensated Heart Failure

## Interventions

- **DRUG:** High-dose furosemide
- **DRUG:** Low-dose furosemide
- **DRUG:** Low-dose furosemide combined with low-dose dopamine

## Key facts

- **NCT ID:** NCT01060293
- **Lead sponsor:** Larissa University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-07
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 161 (ACTUAL)
- **Why stopped:** Safety issues in the LDFD-group (higher heart rate with dopamine)
- **Last updated:** 2013-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01060293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01060293, "Dopamine in Acute Decompensated Heart Failure II". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01060293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*